Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Acute graft-versus-host disease (aGVHD) remains a significant complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Vedolizumab could help prevent aGVHD by inhibiting the migration of both naive and activated lymphocytes into gut-associated lymphoid tissues and the lamina p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Chen, Yi-Bin, Shah, Nirav N., Renteria, Anne S., Cutler, Corey, Jansson, Johan, Akbari, Mona, Chen, Chunlin, Quadri, Syed, Parfionovas, Andrejus, Devine, Steven M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6963235/
https://ncbi.nlm.nih.gov/pubmed/31821456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000893
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados